# High-dose Inhaled NO Therapy for the Prevention of Nosocomial Pneumonia After Cardiac Surgery With CPB

> **NCT06162455** · NA · COMPLETED · sponsor: **Tomsk National Research Medical Center of the Russian Academy of Sciences** · enrollment: 74 (actual)

## Conditions studied

- Nosocomial Pneumonia

## Interventions

- **DRUG:** Sham treatment
- **DRUG:** 200- ppm NO

## Key facts

- **NCT ID:** NCT06162455
- **Lead sponsor:** Tomsk National Research Medical Center of the Russian Academy of Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-17
- **Primary completion:** 2024-01-15
- **Final completion:** 2024-02-06
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2024-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06162455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06162455, "High-dose Inhaled NO Therapy for the Prevention of Nosocomial Pneumonia After Cardiac Surgery With CPB". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT06162455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*